Expanding Product Portfolio CellPath has significantly increased its manufacturing capabilities to include chemicals, stains, tissue marking dyes, and fixatives, presenting opportunities to cross-sell their diverse range of consumables and equipment to laboratories seeking comprehensive histology and cytology solutions.

Strong Global Presence With a focus on worldwide supply and an award-winning export track record, CellPath is well-positioned to expand sales efforts in international markets, especially in regions with growing demand for high-quality medical laboratory supplies.

Acquisition Backing Being acquired by StatLab, a prominent player in medical diagnostic supplies, enhances CellPath’s credibility and resources, making it easier to foster partnerships with larger healthcare providers and institutions seeking trusted suppliers.

Innovation and Certification The company's investment in innovative manufacturing processes such as injection moulding and adherence to ISO 13485:2016 standards suggest a focus on quality and precision, appealing to clients valuing reliable and well-certified laboratory equipment.

Strategic Collaborations Partnerships like the one with KDx Diagnostics for evaluating novel diagnostic tests open avenues for selling compatible lab consumables and equipment that support emerging medical testing applications, thereby expanding market reach.